OGP vs BMP-2
Head-to-head comparison of OGP (Osteogenic Growth Peptide) and BMP-2 (Recombinant Human Bone Morphogenetic Protein-2) — benefits, dosing, side effects, research data, and where to buy.
| Property | OGP | BMP-2 |
|---|---|---|
| Category | Recovery & Healing | Recovery & Healing |
| Full Name | Osteogenic Growth Peptide | Recombinant Human Bone Morphogenetic Protein-2 |
| Molecular Weight | 1600 Da | 26000 Da |
| Half-Life | N/A | short, localized exposure |
| Amino Acids | 14 | 114 |
| Typical Dose | research-dependent low microgram range | 1.5 mg/mL local implant |
| Route | Subcutaneous/Local | Local/Implant |
| Purity | ≥98% | ≥98% |
| Studies Count | 80 | 1500 |
| Research Status | Pre-clinical | Clinical |
OGP Benefits
- ✓stimulates osteoblast activity
- ✓supports fracture repair
- ✓may increase bone matrix deposition
- ✓may improve healing after injury
BMP-2 Benefits
- ✓promotes osteogenesis
- ✓supports nonunion healing
- ✓enhances scaffold-based repair
- ✓may improve defect fill
OGP Dosing
research-dependent microgram or nanomolar dosing|subcutaneous or local experimental delivery|cycle-dependent in studies
BMP-2 Dosing
local implantation on collagen sponge|single intraoperative dose|procedure-specific scaffold delivery
OGP Side Effects
- ⚠uncertain safety profile
- ⚠injection-site irritation
- ⚠theoretical endocrine effects
BMP-2 Side Effects
- ⚠local inflammation
- ⚠ectopic bone formation
- ⚠edema
Research Overview
OGP
OGP has mostly preclinical literature showing effects on bone cell signaling, mineralization, and repair models. It is not as clinically established as teriparatide or BMPs, but it is a genuine peptide in the bone-regeneration literature.
BMP-2
rhBMP-2 has strong clinical and translational literature for bone regeneration, spinal fusion, and defect repair. Its use is primarily local because systemic exposure is not the intended mechanism.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.